In 2023, the procalcitonin (PCT) assay market is expected to be worth US$ 280.6 million. The market is expected to reach US$ 512.9 million by 2033, expanding at an 6.2% CAGR throughout the forecast period. Due to the rising prevalence of sepsis and infectious diseases globally has heightened the demand for accurate and reliable diagnostic tools. PCT assays have emerged as valuable biomarkers for bacterial infections, enabling early detection and timely intervention, thereby improving patient outcomes.

The clinical utility of PCT as a biomarker for bacterial infections has gained recognition among healthcare professionals. PCT has demonstrated its value in differentiating bacterial from viral infections and assessing disease severity. This increased awareness and acceptance of PCT as a reliable indicator have led to its incorporation into clinical guidelines, further driving market growth.

Unlock Peak Performance - Get Your Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-17617

Technological advancements in the field of diagnostic assays have positively impacted the PCT assay market. Innovations in immunoassay platforms, molecular diagnostics, and point-of-care testing have enhanced the sensitivity, specificity, and ease of use of PCT assays. These advancements have bolstered their adoption and expanded their applications in various healthcare settings.

In the time of antibiotic resistance, there is a growing emphasis on antibiotic stewardship programs. PCT assays play a vital role in guiding antibiotic therapy by aiding healthcare providers in making informed decisions about the initiation, duration, and discontinuation of antibiotic treatment. This focus on rational antibiotic use has significantly contributed to the adoption of PCT assays.

Key Takeaways:

·        The procalcitonin (PCT) assay market industry in the United States is predicted to reach US$ 202.0 million by 2033, increasing at a 7.3% CAGR.

·        The procalcitonin (PCT) assay market industry in the United Kingdom is estimated to reach a market size of US$ 26.4 million, expanding at a CAGR of 8.3% by 2033.

·        During the forecast period, the procalcitonin (PCT) assay market industry in China is expected to reach a market value of US$ 62.7 million, securing an 9.1% CAGR.

·        The procalcitonin (PCT) assay market industry in Japan is predicted to reach US$ 20.8 million by 2033, increasing at a 6.7% CAGR.

·        South Korea's procalcitonin (PCT) assay market industry is predicted to achieve a market value of US$ 13.9 million, rising at a 6.0% CAGR during the forecast period.

·        With a CAGR of 8.0% from 2023 to 2033, the serum sample is expected to dominate the procalcitonin (PCT) assay market industry.

·        With a CAGR of 6.5%, the test kits segment is expected to drive the global market throughout the forecast period.

·        With a CAGR of 6.0%, the clinical use segment is anticipated to lead the global market during projected timeframe.

·        With a CAGR of 7.2% from 2023 to 2033, the hospital is expected to dominate the procalcitonin (PCT) assay market industry.

Key Players:

• J. Mitra & Co. Pvt. Ltd.
• Thermo Fisher Scientific Inc.
• Elabscience Biotechnology Inc.
• CUSABIO TECHNOLOGY LLC
• Wuhan Fine Biotech Co., Ltd.
• Company ABclonal, Inc.
• Nanjing Vazyme Biotech Co.,Ltd.
• RayBiotech Life, Inc.
• Hipro Biotechnology Co.,Ltd.
• Vitrosens Biotechnology
• bioMérieux SA
• ELK Biotechnology CO.,Ltd.
• Immuno-Biological Laboratories, Inc.
• BISAF
• Roche Diagnostics

Key Developments:

• In November 2020, Roche and bioMérieux announced a collaboration to improve antibiotic stewardship by developing and providing PCT assays on Roche's cobas platforms.
• In February 2020, bioMérieux received FDA clearance for the Vidas BRAHMS PCT assay, which is an automated immunoassay platform for measuring PCT levels.

Segmentation Analysis of the Procalcitonin (PCT) Assay Market

By Sample Type:

• Serum
• Plasma
• Cell Culture Medium
• Other Biological Fluids

By Product:

• Test Kits
  • Procalcitonin ELISA test kits
  • Procalcitonin CLIA kits
  • PCT Immunochromatography KITS
  • PCT Rapid Test Kit
• Analyzer & Instruments
• Consumables

By Purpose:

• Clinical Use
• Research Use Only

By End User:

• Hospital
• Specialty Clinics
• Academic and Research Institute
• Diagnostics Laboratories

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa